IBIO RSI Chart
Last 7 days
7.0%
Last 30 days
4.8%
Last 90 days
57.1%
Trailing 12 Months
108.6%
Historical Charts for Stock Metrics
Year | Q1 | Q2 | Q3 | Q4 |
---|---|---|---|---|
2024 | 0 | 0 | 0 | 0 |
2023 | 0 | 0 | 0 | 0 |
2022 | 2.5M | 2.1M | 0 | 0 |
2021 | 3.0M | 2.4M | 2.0M | 1.5M |
2020 | 1.3M | 1.6M | 1.9M | 2.3M |
2019 | 1.3M | 2.0M | 2.1M | 1.7M |
2018 | 500.0K | 444.0K | 367.0K | 865.0K |
2017 | 522.0K | 394.0K | 381.0K | 459.0K |
2016 | 989.0K | 948.0K | 923.0K | 864.0K |
2015 | 1.4M | 1.9M | 1.2M | 959.0K |
2014 | 0 | 205.0K | 616.5K | 1.0M |
2013 | 741.1K | 1.0M | 0 | 0 |
2012 | 1.1M | 1.3M | 1.3M | 1.1M |
2011 | 0 | 520.1K | 709.3K | 898.5K |
Datesorted ascending | Name | Buy/Sell | $ Value | Avg. Price | # Shares | Title |
---|---|---|---|---|---|---|
Nov 01, 2023 | brenner martin | sold | -1,295 | 0.2655 | -4,881 | see remarks |
Oct 03, 2023 | brenner martin | sold | -1,591 | 0.3022 | -5,267 | see remarks |
Oct 02, 2023 | brenner martin | sold | -1,310 | 0.311 | -4,215 | see remarks |
Aug 28, 2023 | brenner martin | sold | -1,528 | 0.3051 | -5,011 | see remarks |
Jul 27, 2023 | brenner martin | sold | -2,307 | 0.511091 | -4,515 | see remarks |
Jul 12, 2023 | brenner martin | sold | -27,520 | 0.5853 | -47,020 | see remarks |
Jun 26, 2023 | brenner martin | acquired | - | - | 75,833 | see remarks |
Jun 22, 2023 | brenner martin | back to issuer | - | - | -75,833 | see remarks |
Jun 21, 2023 | brenner martin | sold | -2,848 | 0.680898 | -4,184 | see remarks |
May 22, 2023 | brenner martin | sold | -3,910 | 0.935057 | -4,182 | see remarks |
Which funds bought or sold IBIO recently?
View All DetailsDatesorted ascending | Fund Name | Type | % Chg | $ Change | $ Held | % Portfolio |
---|---|---|---|---|---|---|
May 17, 2024 | Ikarian Capital, LLC | new | - | 2,436,000 | 2,436,000 | 0.27% |
May 15, 2024 | Royal Bank of Canada | reduced | -33.33 | - | - | -% |
May 15, 2024 | Tower Research Capital LLC (TRC) | added | 17.14 | 16,195 | 22,748 | -% |
May 15, 2024 | SABBY MANAGEMENT, LLC | reduced | -92.08 | -185,305,000 | 56,840,000 | 0.03% |
May 15, 2024 | Opaleye Management Inc. | new | - | 2,760,800 | 2,760,800 | 0.63% |
May 15, 2024 | ARMISTICE CAPITAL, LLC | new | - | 1,424,560 | 1,424,560 | 0.02% |
May 15, 2024 | Steward Partners Investment Advisory, LLC | unchanged | - | 8.00 | 12.00 | -% |
May 15, 2024 | ADAR1 Capital Management, LLC | new | - | 2,192,400 | 2,192,400 | 0.50% |
May 15, 2024 | MORGAN STANLEY | reduced | -20.94 | 624 | 1,088 | -% |
May 14, 2024 | SRS Capital Advisors, Inc. | unchanged | - | 3.00 | 5.00 | -% |
Unveiling iBio Inc's Major ShareHolders
Date Filed | Name of Filer | Percent of Class | No. of Shares | Form Type | |
---|---|---|---|---|---|
Peers (Alternatives to iBio Inc)
Name | Mkt Capsorted ascending | Revenue | Price %, 1M | Returns, 1Y | P/E | P/S | Rev 1-Yr | Inc 1-Yr |
---|---|---|---|---|---|---|---|---|
LARGE-CAP | ||||||||
MRNA | 50.9B | 6.8B | -8.53 | 7.44 | ||||
HILS | 22.5B | 216.3K | -2.5K | 104.0K | ||||
ALNY | 18.9B | 2.0B | -56.9 | 9.43 | ||||
BMRN | 14.7B | 2.5B | 71.65 | 5.96 | ||||
INCY | 12.8B | 3.8B | 17.2 | 3.4 | ||||
MID-CAP | ||||||||
BBIO | 5.6B | 107.9M | -10.31 | 48.09 | ||||
APLS | 5.0B | 524.1M | -12.02 | 9.57 | ||||
AXSM | 3.6B | 251.0M | -12.28 | 14.5 | ||||
ARWR | 3.1B | 240.7M | -6.53 | 12.77 | ||||
ACAD | 2.4B | 813.8M | -1.4K | 3 | ||||
SMALL-CAP | ||||||||
CPRX | 1.9B | 411.3M | 29.91 | 4.73 | ||||
NVAX | 1.8B | 996.6M | -4.58 | 1.83 | ||||
CRBP | 480.9M | 881.7K | -14.25 | 481.06 | ||||
INO | 310.9M | 4.9M | -2.49 | 63.89 | ||||
IBIO | 17.1M | 2.1M | -0.74 | 7.61 |
iBio Inc News
Income Statement (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 | 2018Q4 | 2018Q3 | 2018Q2 | 2018Q1 |
Revenue | - | - | - | - | - | 1,800 | 168 | 84.00 | 491 | 765 | 705 | 410 | 1,120 | 96.00 | 314 | 108 | 795 | 527 | 651 | 45.00 | 91.00 | 78.00 |
Gross Profit | - | - | - | - | 46.00 | 1,895 | 55.00 | 171 | 72.00 | 272 | 494 | 303 | - | 10.00 | - | - | - | - | - | - | - | - |
Operating Expenses | -19.4% | 3,626 | 4,496 | 5,153 | 10,453 | 8,588 | 7,231 | 5,309 | 9,511 | 7,475 | 8,039 | 7,227 | 3,591 | 4,074 | 3,469 | 3,963 | 4,848 | 4,297 | 4,666 | 3,995 | 4,037 | - |
S&GA Expenses | -100.0% | - | 2,961 | 3,547 | 6,891 | 5,316 | 5,372 | 4,175 | 6,167 | 5,313 | 5,665 | 5,365 | 2,993 | 2,979 | 2,581 | 2,986 | 3,224 | 2,844 | 3,393 | 2,871 | 2,995 | 2,605 |
R&D Expenses | -41.1% | 904 | 1,535 | 1,606 | 3,562 | 3,272 | 1,859 | 1,134 | 3,344 | 2,162 | 2,374 | 1,862 | 598 | 1,095 | 888 | 977 | 1,624 | 1,453 | 1,273 | 1,124 | 1,042 | - |
Interest Expenses | 52.9% | 52.00 | 34.00 | 26.00 | 310 | - | - | 610 | 613 | 612 | 615 | 614 | 615 | 616 | 615 | 620 | 474 | 474 | 476 | 476 | 478 | - |
Net Income | 61.4% | -3,172 | -8,211 | -5,746 | -17,054 | -12,390 | -11,920 | -8,940 | 118 | -7,661 | -8,131 | -7,534 | -3,536 | -4,676 | -3,764 | -4,464 | -4,502 | -4,223 | -4,470 | -4,399 | -8,244 | - |
Net Income Margin | 15.1% | -11.29* | -13.30* | -25.65* | -24.51* | -13.03* | -18.84* | -12.04* | -9.79* | -8.95* | - | - | - | - | - | - | - | - | - | - | - | - |
Free Cashflow | 22.4% | -3,654 | -4,706 | -5,846 | -14,933 | -6,588 | -12,819 | -10,470 | -9,740 | -8,342 | - | - | - | - | - | - | - | - | - | - | - | - |
Balance Sheet | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Assets | 47.4% | 50,154 | 34,022 | 37,678 | 41,207 | 44,386 | 51,800 | 84,564 | 99,406 | 115,370 | 126,448 | 143,739 | 146,968 | 142,697 | 145,406 | 117,255 | 94,189 | 42,220 | 36,384 | 35,164 | 30,586 | 35,674 |
Current Assets | 83.5% | 36,139 | 19,699 | 23,022 | 26,259 | 27,093 | 38,235 | 63,565 | 45,070 | 60,316 | 67,496 | 89,817 | 104,597 | 107,203 | 110,882 | 84,959 | 61,748 | 10,304 | 4,007 | 2,361 | 4,808 | 9,586 |
Cash Equivalents | 130.7% | 6,431 | 2,788 | 1,461 | 4,301 | 6,562 | 3,949 | 15,883 | 28,672 | 39,708 | 45,145 | 62,820 | 77,404 | 84,627 | 91,252 | 77,543 | 55,112 | 10,040 | 3,637 | 2,103 | 4,421 | 9,037 |
Inventory | - | - | - | - | - | - | - | - | 3,900 | 3,283 | 1,986 | 587 | 27.00 | - | - | - | - | - | - | - | - | - |
Net PPE | -4.2% | 3,726 | 3,890 | 4,054 | 4,219 | 4,358 | 4,245 | 3,464 | 1,373 | 34,581 | 32,881 | 9,821 | 8,628 | 6,407 | 5,010 | 3,834 | 3,657 | 2,657 | 2,658 | 2,594 | 24,380 | 24,641 |
Liabilities | 1.9% | 25,291 | 24,825 | 24,469 | 25,826 | 26,997 | 32,977 | 36,196 | 35,921 | 35,990 | 35,850 | 43,214 | 38,400 | 37,867 | 38,085 | 37,212 | 37,582 | 38,263 | 36,904 | 37,104 | 28,129 | 28,772 |
Current Liabilities | -0.6% | 21,426 | 21,553 | 20,708 | 21,582 | 22,276 | 27,775 | 32,199 | 30,436 | 8,281 | 8,346 | 8,098 | 6,645 | 6,067 | 6,102 | 5,046 | 5,236 | 6,179 | 4,744 | 4,869 | 3,458 | 4,046 |
Shareholder's Equity | 170.3% | 24,863 | 9,197 | 13,209 | 15,381 | 17,389 | 18,823 | 48,368 | 63,485 | 79,380 | 90,598 | 100,525 | 108,568 | 104,830 | 107,321 | 80,042 | 56,607 | 3,957 | - | - | 2,457 | 6,902 |
Retained Earnings | -1.0% | -306,069 | -302,897 | -294,686 | -288,940 | -282,907 | -275,613 | -242,060 | -223,930 | -206,876 | -194,486 | -182,566 | -173,627 | -173,743 | -166,082 | -157,953 | -150,420 | -146,882 | -135,606 | -110,284 | -105,821 | -101,318 |
Additional Paid-In Capital | 6.0% | 330,923 | 312,064 | 307,867 | 304,301 | 300,280 | 294,591 | 290,642 | 287,619 | 286,232 | 284,957 | 282,956 | 282,266 | 278,442 | 273,258 | 237,867 | 206,931 | 150,774 | 135,071 | 108,359 | 108,295 | 108,236 |
Accumulated Depreciation | - | 893 | - | - | 400 | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - | - |
Shares Outstanding | 162.6% | 8,517 | 3,244 | 1,383 | 1,016 | 618 | 466 | 442 | 436 | 436 | 436 | 436 | 436 | 377 | - | - | - | - | - | - | - | - |
Minority Interest | - | - | - | - | - | - | - | - | - | - | - | -18.00 | -17.00 | -15.00 | -14.00 | -12.00 | -11.00 | -9.00 | -9.00 | -7.00 | -6.00 | -5.00 |
Float | - | - | - | - | - | - | 5,436 | - | - | - | 119,731 | - | - | - | 222,358 | - | - | - | 13,642 | - | - | - |
Cashflow (Quarterly) | ||||||||||||||||||||||
Description | (%) Q/Q | 2024Q1 | 2023Q4 | 2023Q3 | 2023Q2 | 2023Q1 | 2022Q4 | 2022Q3 | 2022Q2 | 2022Q1 | 2021Q4 | 2021Q3 | 2021Q2 | 2021Q1 | 2020Q4 | 2020Q3 | 2020Q2 | 2020Q1 | 2019Q4 | 2019Q3 | 2019Q2 | 2019Q1 |
Cashflow From Operations | 22.4% | -3,654 | -4,706 | -5,340 | -4,970 | -3,872 | -7,635 | -13,959 | -11,503 | -5,944 | -10,686 | -9,347 | -7,226 | -7,349 | -8,419 | -7,070 | -3,867 | -3,786 | -3,405 | -2,287 | -4,392 | -4,135 |
Share Based Compensation | 0.2% | 457 | 456 | 765 | 446 | 1,596 | 1,127 | 1,222 | 1,179 | 1,274 | 1,103 | 821 | 596 | 374 | 265 | 351 | 220 | 63.00 | 37.00 | 68.00 | 59.00 | 49.00 |
Cashflow From Investing | - | 1,000 | - | 50.00 | -6.00 | 8,241 | -1,255 | 29.00 | 477 | 517 | -972 | -5,149 | -2,908 | -4,014 | -12,956 | -6,600 | -820 | -96.00 | -208 | -30.00 | -173 | -139 |
Cashflow From Financing | 25.5% | 5,025 | 4,005 | 2,472 | 2,740 | 1,464 | -3,044 | 1,141 | -10.00 | -10.00 | -6,017 | -88.00 | 2,912 | 4,738 | 35,084 | 36,101 | 49,759 | 10,287 | 5,146 | - | -50.00 | -50.00 |
Condensed Consolidated Statements of Operations and Comprehensive Loss - USD ($) shares in Thousands, $ in Thousands | 3 Months Ended | 9 Months Ended | ||
---|---|---|---|---|
Mar. 31, 2024 | Mar. 31, 2023 | Mar. 31, 2024 | Mar. 31, 2023 | |
Condensed Consolidated Statements of Operations and Comprehensive Loss | ||||
Revenues | $ 50 | |||
Operating expenses: | ||||
Research and development | $ 904 | $ 2,644 | 4,045 | $ 7,971 |
General and administrative | 2,722 | 3,525 | 9,230 | 16,407 |
Total operating expenses | 3,626 | 6,169 | 13,275 | 24,378 |
Operating loss | (3,626) | (6,169) | (13,225) | (24,378) |
Other income (expense): | ||||
Interest expense | (52) | (35) | (112) | (66) |
Interest income | 43 | 23 | 140 | 163 |
Loss on sale of debt securities | (98) | (98) | ||
Gain on sale of intellectual property | 1,000 | 1,000 | 0 | |
Total other income | 991 | (110) | 1,028 | (1) |
Net loss from continuing operations | (2,635) | (6,279) | (12,197) | (24,379) |
Loss from discontinued operations | (537) | (1,015) | (4,932) | (34,598) |
Net loss | (3,172) | (7,294) | (17,129) | (58,977) |
Comprehensive loss: | ||||
Consolidated net loss | (3,172) | (7,294) | (17,129) | (58,977) |
Other comprehensive loss - unrealized loss on debt securities | 134 | 180 | ||
Other comprehensive income - foreign currency adjustment | 33 | 33 | ||
Comprehensive loss | $ (3,172) | $ (7,127) | $ (17,129) | $ (58,764) |
Loss per common share attributable to iBio, Inc. stockholders - basic - continuing operations | $ (0.71) | $ (9.53) | $ (5.43) | $ (46.00) |
Loss per common share attributable to iBio, Inc. stockholders - diluted - continuing operations | (0.71) | (9.53) | (5.43) | (46.00) |
Loss per common share attributable to iBio, Inc. stockholders - basic - discontinued operations | (0.14) | (1.54) | (2.19) | (65.28) |
Loss per common share attributable to iBio, Inc. stockholders - diluted - discontinued operations | (0.14) | (1.54) | (2.19) | (65.28) |
Loss per common share attributable to iBio, Inc. stockholders - basic - total | (0.85) | (11.07) | (7.62) | (111.28) |
Loss per common share attributable to iBio, Inc. stockholders - diluted - total | $ (0.85) | $ (11.07) | $ (7.62) | $ (111.28) |
Weighted-average common shares outstanding - basic | 3,713 | 659 | 2,247 | 530 |
Weighted-average common shares outstanding - diluted | 3,713 | 659 | 2,247 | 530 |
Condensed Consolidated Balance Sheets - USD ($) | Mar. 31, 2024 | Jun. 30, 2023 |
---|---|---|
Current assets: | ||
Cash and cash equivalents | $ 5,302,000 | $ 4,301,000 |
Restricted cash | 914,000 | 3,025,000 |
Subscription receivable | 14,104,000 | 204,000 |
Prepaid expenses and other current assets | 862,000 | 664,000 |
Current assets held for sale | 14,957,000 | 18,065,000 |
Total Current Assets | 36,139,000 | 26,259,000 |
Restricted cash | 215,000 | 253,000 |
Promissory note receivable and accrued interest | 1,772,000 | 1,706,000 |
Net finance lease ROU assets | 407,000 | 610,000 |
Operating lease right-of-use asset | 2,472,000 | 2,722,000 |
Fixed assets, net of accumulated depreciation | 3,726,000 | 4,219,000 |
Intangible assets, net of accumulated amortization | 5,373,000 | 5,388,000 |
Security deposits | 50,000 | 50,000 |
Total Assets | 50,154,000 | 41,207,000 |
Current liabilities: | ||
Accounts payable | 1,228,000 | 1,849,000 |
Accrued expenses | 3,998,000 | 4,034,000 |
Finance lease obligations - current portion | 292,000 | 272,000 |
Operating lease obligation - current portion | 424,000 | 389,000 |
Equipment financing payable - current portion | 173,000 | 160,000 |
Term promissory note - current portion | 208,000 | |
Insurance premium financing payable | 340,000 | |
Term note payable - net of deferred financing costs | 12,655,000 | 12,937,000 |
Contract liabilities | 175,000 | |
Current liabilities related to assets held for sale | 1,933,000 | 1,941,000 |
Total Current Liabilities | 21,426,000 | 21,582,000 |
Finance lease obligations - net of current portion | 130,000 | 351,000 |
Operating lease obligation - net of current portion | 2,801,000 | 3,125,000 |
Equipment financing payable - net of current portion | 110,000 | 241,000 |
Term promissory note - net of current portion | 824,000 | |
Accrued expenses - noncurrent | 527,000 | |
Total Liabilities | 25,291,000 | 25,826,000 |
Stockholders' Equity | ||
Series 2022 Convertible Preferred Stock - $0.001 par value; 1,000,000 shares authorized at December 31, 2023 and June 30, 2023; 0 and 0 shares issued and outstanding as of December 31, 2023 and June 30, 2023, respectively | ||
Common Stock - $0.001 par value; 275,000,000 shares authorized at December 31, 2023 and June 30, 2023; 3,243,725 and 1,015,505 shares issued and outstanding as of December 31, 2023 and June 30, 2023, respectively | 9,000 | 1,000 |
Additional paid-in capital | 330,923,000 | 304,320,000 |
Accumulated deficit | (306,069,000) | (288,940,000) |
Total Stockholders' Equity | 24,863,000 | 15,381,000 |
Total Liabilities and Stockholders' Equity | $ 50,154,000 | $ 41,207,000 |